Advertisement

Topics

Ivantis Announces Results of Landmark Prospective, Randomized Comparative MIGS Clinical Trial

07:05 EDT 16 Apr 2018 | BioMedReports - Blog

COMPARE is the first prospective, multi-center, randomized trial comparing two MIGS devices, the Hydrus Microstent versus two large-diameter iStent® Trabecular Micro-bypass stents, for the treatment

Read more...

Original Article: Ivantis Announces Results of Landmark Prospective, Randomized Comparative MIGS Clinical Trial

NEXT ARTICLE

More From BioPortfolio on "Ivantis Announces Results of Landmark Prospective, Randomized Comparative MIGS Clinical Trial"

Advertisement
Quick Search
Advertisement
Advertisement